Abstract Details

Title Time to Efficacy and Responder Rates of Lamotrigine Extended-Release Adjunctive Therapy in Subjects with Partial Seizures: A Randomized, Double-Blind, Placebo-Controlled Study

Topic Epilepsy

Presentation(s) (-)

Poster/Presentation
Number 051

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Kevan E. VanLandingham, MD, PhD, FAAN (US Food and Drug Administration)	Dr. VanLandingham has received personal compensation for serving as an employee of Greenwich Biosciences. Dr. VanLandingham has received stock or an ownership interest from Greenwich Biosciences.
	No disclosure on file
	No disclosure on file
Heather S. Conklin (GlaxoSmithkline)	No disclosure on file
Alain Vuong (GlaxoSmithKline)	No disclosure on file
	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��